PHI with Idiopathic thrombocytopenic purpura (ITP)
How does this condition affect your private health insurance?
Werlhofkrankheit, also known as Immune Thrombocytopenia (ITP), is an autoimmune bleeding disorder characterized by a low platelet count. The immune system mistakenly attacks and destroys platelets, leading to increased risk of bleeding. Symptoms include easy bruising, petechiae (small red spots), purpura (larger purple patches), nosebleeds, and gum bleeding. In severe cases, internal hemorrhage, including intracranial bleeding, can occur. It affects both children and adults, often acutely in children but frequently becoming chronic in adults. Diagnosis involves ruling out other causes of thrombocytopenia. Treatment aims to elevate platelet counts and prevent serious bleeding, typically starting with corticosteroids or intravenous immunoglobulin.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Can be acute, resolving within weeks to months (especially in children), or present as chronic, requiring ongoing management from onset.
Duration of Illness (Lifetime)
For acute forms, it can be a one-time event with full recovery. For chronic Werlhofkrankheit, it can persist for years or be lifelong, requiring continuous medical supervision.
Cost of Treatment (Initial)
Ranges from hundreds to several thousands of euros/dollars, depending on severity, specific treatments (e.g., corticosteroids versus IVIG), and hospitalization needs.
Cost of Treatment (Lifetime)
For chronic cases, costs can accumulate to tens of thousands to hundreds of thousands of euros/dollars over a lifetime, including ongoing medication, monitoring, and potential advanced therapies or splenectomy.
Mortality Rate
Low (approximately 1-2% in adults, even lower in children), primarily due to severe, uncontrolled bleeding, particularly intracranial hemorrhage.
Risk of Secondary Damages
Potential for chronic fatigue, anemia from persistent bleeding, psychological stress, and side effects from long-term treatments (e.g., osteoporosis or cataracts from corticosteroids). Severe bleeding can lead to organ damage.
Probability of Full Recovery
High for acute ITP in children (around 80%). For adults, spontaneous remission is less common (30-40% for acute cases), with many progressing to chronic ITP. Treatment can achieve remission, but not always a permanent 'cure'.
Underlying Disease Risk
While often idiopathic, it can be secondary to other autoimmune diseases (e.g., SLE), infections (e.g., H. pylori, HIV, hepatitis C), certain lymphoproliferative disorders, or drug-induced. Investigation for underlying causes is part of the diagnostic process.